These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 582335)

  • 41. Health risk and regulatory aspects of aflatoxin.
    Robens JF
    Vet Hum Toxicol; 1980 Aug; 22(4):264-6. PubMed ID: 7404988
    [No Abstract]   [Full Text] [Related]  

  • 42. Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey.
    van Wagenen G; DeConti RC; Handschumacher RE; Wade ME
    Am J Obstet Gynecol; 1970 Sep; 108(2):272-81. PubMed ID: 4952580
    [No Abstract]   [Full Text] [Related]  

  • 43. To live or not to live with the risk of extra-label use.
    Herrick JB
    J Am Vet Med Assoc; 1992 Jun; 200(12):1827. PubMed ID: 1639684
    [No Abstract]   [Full Text] [Related]  

  • 44. Of mice and psoriatics.
    Schiffrin MJ
    Ann Allergy; 1980 Oct; 45(4):266-7. PubMed ID: 6893529
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of the Food and Drug Administration in the regulation of the products of recombinant DNA technology.
    Goldberg M; Miller HI
    Recomb DNA Tech Bull; 1981 Apr; 4(1):15-8. PubMed ID: 7255754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Legal developments in the enforcement of food and drug law.
    Masoudi GF
    Food Drug Law J; 2008; 63(2):585-92. PubMed ID: 18561479
    [No Abstract]   [Full Text] [Related]  

  • 47. A few observations from my first year in Washington.
    Hoeting AL
    J Parenter Sci Technol; 1990; 44(3):150-2. PubMed ID: 2370624
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
    Scheuplein RJ
    Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The new law: public law 109-462 for dietary supplements.
    Jiang T
    Eur J Clin Nutr; 2009 Feb; 63(2):300. PubMed ID: 17851457
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug and other hazards to the fetus and newborn.
    Freeman MM; Finkel MJ
    Prog Clin Biol Res; 1980; 36():67-72. PubMed ID: 7403181
    [No Abstract]   [Full Text] [Related]  

  • 51. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Social policy and drug safety.
    Tilson HH
    Clin Geriatr Med; 1986 Feb; 2(1):165-80. PubMed ID: 3513933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 54. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(26):563-5. PubMed ID: 10418806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. To serve well and not to please: an FDA dilemma.
    Larkin T
    FDA Consum; 1976 Oct; 10(8):14-8. PubMed ID: 829441
    [No Abstract]   [Full Text] [Related]  

  • 56. AVMA legislation: partial solution to drug availability problem.
    Gloyd JS
    J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
    [No Abstract]   [Full Text] [Related]  

  • 57. Food and Drug Administration--part II: Federal agency close-up.
    Kauffman NM; Malevich S; Smith DJ; Petersen-Kauffman LC
    Am J Med Technol; 1980 Jul; 46(7):527-37. PubMed ID: 7405954
    [No Abstract]   [Full Text] [Related]  

  • 58. Food and Drug Administration--part I: Federal agency close-up.
    Kauffman NM; Malevich S; Smith DJ; Petersen-Kauffman LC
    Am J Med Technol; 1980 Jun; 46(6):428-36. PubMed ID: 7386516
    [No Abstract]   [Full Text] [Related]  

  • 59. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. American Pharmaceutical Association House of Delegates, May 13-18 1978, Montreal, Quebec, Canada. Report of the Policy Committe on Public Affairs.
    Am Pharm; 1978 Jul; 18(8 Spec No):22-9. PubMed ID: 665504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.